Biomarker testing and Bioanalysis have the potential of reducing time and costs in the process of drug development. By enabling the availability of a wide range of biomarkers during the clinical trials.
https://ed.ted.com/on/203Tdjiv#digdeeper
 

comments (0)

63 more from nebiolab